Low lipoprotein(a) concentration is associated with atrial fibrillation: a large retrospective cohort study

Junjie Tao1,2, Xinlei Yang3, Qingkai Qiu1,2

  • 1Department of Cardiovascular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.

Insights

Low serum lipoprotein(a) [Lp(a)] levels are linked to a higher risk of atrial fibrillation (AF), particularly in women. This finding suggests Lp(a) may aid in AF risk stratification for females.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Epidemiology

Background:

  • The association between serum lipoprotein(a) [Lp(a)] levels and atrial fibrillation (AF) remains unclear, particularly within the Chinese population.
  • Investigating Lp(a) levels is crucial for understanding AF pathogenesis and developing targeted prevention strategies.

Purpose of the Study:

  • To determine the relationship between serum Lp(a) quantiles and the prevalence of atrial fibrillation (AF) in a Chinese cohort.
  • To explore the potential of Lp(a) as a biomarker for AF risk stratification, especially in specific demographic groups.

Main Methods:

  • Retrospective analysis of electronic health records from 4,511 AF patients and 9,022 controls (2017-2021).
  • Propensity score matching (PSM) was employed to create comparable case and control groups.
  • Logistic regression and stratified analyses were used to examine interactions between AF, Lp(a) quantiles, and clinical factors.

Main Results:

  • Patients with AF exhibited significantly lower median Lp(a) levels compared to those without AF (15.95 vs. 16.90 mg/dL; P < 0.001).
  • Lower Lp(a) quantiles (Q1-Q3) were associated with an increased prevalence of AF in unadjusted models.
  • An inverse association between Lp(a) levels < 32.42 mg/dL and AF was observed in the adjusted model. Stratified analysis revealed a significant negative correlation between Lp(a) and AF in female patients (OR of Q1: 1.394 [1.194-1.626]).

Conclusions:

  • Low serum Lp(a) levels are significantly associated with an increased risk of AF, particularly in the female Han Chinese population.
  • Serum Lp(a) may serve as a valuable biomarker for identifying individuals at higher risk of developing AF, especially among women.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
19
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
37
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
219
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
768